112
Participants
Start Date
January 31, 2003
Primary Completion Date
February 28, 2009
Study Completion Date
March 31, 2009
Generic HAART Triomune : d4T, 3TC, NVP
Triomune® (Cipla, Mumbai) Stavudine 40mg b.d \> 60 kg , 30mg bd \<60kg Lamivudine 150mg b.d \> 50 kg 2mg/kg \< 50 kg Nevirapine 200mg b.d ( 200mg daily for first 2 weeks)
Generic HAART Triomune : d4T, 3TC, NVP and chemotherapy ABV
Triomune® (Cipla, Mumbai) Stavudine 40mg b.d \> 60 kg , 30mg bd \<60kg Lamivudine 150mg b.d \> 50 kg 2mg/kg \< 50 kg Nevirapine 200mg b.d ( 200mg daily for first 2 weeks) Intramuscular Bleomycin 10 U/m2 ; Intravenous Vincristine 1.4mg/m2 maximum 2mg and Intravenous Doxorubicin 20mg/m2.
Department of Dermatology, King Edward VIII Hospital, Durban
AIDS Care Research in Africa
OTHER
National Research Foundation, Singapore
OTHER_GOV
AIDS Malignancy Consortium
NETWORK
Cipla Medpro
INDUSTRY
Dermatological Society of South Africa
UNKNOWN
University of KwaZulu
OTHER